Close Menu

NEW YORK – Becton Dickinson will collaborate with Scanwell Health to develop an at-home rapid test for SARS-CoV-2, the firms said on Monday.

Financial terms of the collaboration were not disclosed.

The assay will use a BD viral antigen test and the Scanwell Health mobile app. For the collaboration, BD will produce a lateral flow antigen test and pair it with the Scanwell Health mobile app, the Franklin Lakes, New Jersey firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.